Treatment of Recurrent Herpes Simplex Labialis with Levamisole

Because deficient immune responses may play a contributory role in recurrent herpes simplex labialis, an immunomodulating agent, levamisole, has been advocated for therapy. Forty-two patients with a high frequency of recurrent herpes simplex labialis were followed for a mean of 7.8 months (range 4 t...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Spruance, S. L., Krueger, G. G., MacCalman, J., Overall, J. C., Klauber, M. R.
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1979
Fag:	Pharmacology and Therapeutics
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352734/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/525982/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.15.5.662
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!